Induction of DC in Human Serum AB+
| . | CD1a+ CD14− . | CD1a−CD14+ . | CD83 . | CD86 . | CD40 . | HLA-DR . |
|---|---|---|---|---|---|---|
| 24 d FLT3-L + TPO | 3.9 ± 4.8 | 54 ± 4.0 | 5.6 ± 2.3 | 39 ± 19 | 40 ± 20 | 74 ± 28 |
| 3 d G4 | 47 ± 3.0 | 3.9 ± 3.5 | 5.6 ± 2.3 | 31 ± 18 | 67 ± 13 | 84 ± 20 |
| 3 d G4 8 d GT4 | 38 ± 1.4 | 16 ± 15 | 57 ± 32 | 69 ± 1.0 | 66 ± 19 | 90 ± 7.0 |
| . | CD1a+ CD14− . | CD1a−CD14+ . | CD83 . | CD86 . | CD40 . | HLA-DR . |
|---|---|---|---|---|---|---|
| 24 d FLT3-L + TPO | 3.9 ± 4.8 | 54 ± 4.0 | 5.6 ± 2.3 | 39 ± 19 | 40 ± 20 | 74 ± 28 |
| 3 d G4 | 47 ± 3.0 | 3.9 ± 3.5 | 5.6 ± 2.3 | 31 ± 18 | 67 ± 13 | 84 ± 20 |
| 3 d G4 8 d GT4 | 38 ± 1.4 | 16 ± 15 | 57 ± 32 | 69 ± 1.0 | 66 ± 19 | 90 ± 7.0 |
G4, GT4 as in Table 1. The data represent the percentage of positive cells. This is the mean of two independent experiments; SDs are shown.